IDENTIFICATION OF MOUSE CYP2C INVOLVED IN ARACHIDONIC ACID

花生四烯酸相关小鼠CYP2C的鉴定

基本信息

项目摘要

AIMS: Little is known about the endogenous function of the CYP2Cs. We postulate that these enzymes have important roles in the metabolism of physiologically important endogenous substrates such as arachidonic acid and retinoic acid (Vitamin A). Our goal has been to identify all CYP2Cs in the mouse, determine their contribution to the production of particular eicosanoid metabolites and to identify their physiological role in these tissues. The P450-derived AA metabolites are known to possess potent biological actions in numerous tissues. These effects depend on the regio- and stereochemistry of the products. We are attempting to determine the organ and cell-specific localization of these isoforms. A long-range goal is to produce knockout mice to study the physiological importance of this class of enzymes, and to overexpress these enzymes in cell lines to further establish their function. ACCOMPLISHMENTS We have identified five (potentially six) CYP2Cs in the mouse. We expressed five of these in cDNA expression systems examined their regio and stereospecificity in the formation of epoxyeicosatrienoic acids (EETs) and hydroxyeicosatetraenoic acids (HETES). They were found to produce very specific regiospecific and stereospecific products. CYP2C29 is the predominant hepatic form and produces 14,15-EET. Western blotting and RT-PCR indicted that lung contained relatively large amounts of CYP2C29. CYP2C40 was found in high amounts in colon, cecum, gut, and was also found in kidney and heart. CYP2C40 was found to metabolize arachidonic acid (AA) to 16R- HETE (66%) and 16S-HETE (34%). This is the first P450 found to produce this HETE as a primary product. 16R-HETE is thought to be important in processes such as renal vasodilation and inhibiting neutrophil aggregation and adhesion. Kidney contained CYP2C40 and a new unidentified CYP2C isoform. Endothelial cells of arteries contained CYP2C29 and some CYP2C40. - endogenous compound, arachidonic acid, retinoic acid, Vitamin A, epoxyeicosatrienoic acid
目的:关于CYP2Cs的内源性功能知之甚少。我们假设这些酶在生理上重要的内源性底物如花生四烯酸和维甲酸(维生素A)的代谢中起重要作用。我们的目标是确定小鼠中所有CYP2Cs,确定它们对特定类二十烷代谢产物产生的贡献,并确定它们在这些组织中的生理作用。已知p450衍生的AA代谢物在许多组织中具有强大的生物作用。这些效应取决于产物的区域化学和立体化学。我们正试图确定这些同种异构体的器官和细胞特异性定位。一个长期的目标是产生基因敲除小鼠来研究这类酶的生理重要性,并在细胞系中过表达这些酶以进一步确定它们的功能。我们已经在小鼠体内发现了5种(可能是6种)CYP2Cs。我们在cDNA表达系统中表达了其中的5个,并检测了它们在环氧二十碳三烯酸(EETs)和羟基二十碳四烯酸(HETES)形成中的区域和立体特异性。它们被发现产生非常特定的区域特异性和立体特异性产物。CYP2C29是主要的肝脏形式,产生14,15- eet。Western blotting和RT-PCR检测显示肺组织中CYP2C29含量较高。CYP2C40在结肠、盲肠、肠道中含量较高,在肾脏和心脏中也有发现。发现CYP2C40将花生四烯酸(AA)代谢为16R- HETE(66%)和16S-HETE(34%)。这是第一个将HETE作为主要产品生产的P450。16R-HETE被认为在肾脏血管扩张和抑制中性粒细胞聚集和粘附等过程中很重要。肾脏含有CYP2C40和一个新的未知CYP2C亚型。动脉内皮细胞中含有CYP2C29和部分CYP2C40。-内源性化合物,花生四烯酸,维甲酸,维生素A,环氧二碳三烯酸

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOYCE GOLDSTEIN其他文献

JOYCE GOLDSTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOYCE GOLDSTEIN', 18)}}的其他基金

DRUG METABOLIZING ENZYMES IN HUMANS AND ANIMAL MODELS
人类和动物模型中的药物代谢酶
  • 批准号:
    6106559
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Mouse Cyp2c Involved In Arachidonic Acid
小鼠 Cyp2c 参与花生四烯酸
  • 批准号:
    6504701
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Drug Metabolizing Enzymes In Humans And Animal Models
人类和动物模型中的药物代谢酶
  • 批准号:
    6504693
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Structure-Function of Drug Metabolizing Enzymes
药物代谢酶的结构-功能
  • 批准号:
    6432314
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Identification Of Mouse Cyp2c Involved In Arachidonic Ac
小鼠 Cyp2c 参与花生四烯酸的鉴定
  • 批准号:
    6673249
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Drug Metabolizing Enzymes In Humans And Animal Models
人类和动物模型中的药物代谢酶
  • 批准号:
    7967941
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Drug Metabolizing Enzymes In Humans
人体药物代谢酶
  • 批准号:
    8929701
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Drug Metabolizing Enzymes In Humans And Animal Models
人类和动物模型中的药物代谢酶
  • 批准号:
    6672817
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Specificity And Structure-function Studies Of Human Drug
人类药物的特异性和结构功能研究
  • 批准号:
    6672934
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Drug Metabolizing Enzymes In Humans And Animal Models
人类和动物模型中的药物代谢酶
  • 批准号:
    8148978
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Inter-Enzyme Crosstalk in the Cytochrome P450 Ensemble: Implications for the Effects of Alcohol on Drug Metabolism and Alcohol-Drug Interactions
细胞色素 P450 整体中的酶间串扰:酒精对药物代谢和酒精-药物相互作用影响的影响
  • 批准号:
    10704053
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Inter-Enzyme Crosstalk in the Cytochrome P450 Ensemble: Implications for the Effects of Alcohol on Drug Metabolism and Alcohol-Drug Interactions
细胞色素 P450 整体中的酶间串扰:酒精对药物代谢和酒精-药物相互作用影响的影响
  • 批准号:
    10445619
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Thalidomide increases cytochrome P450 activity and drug metabolism in liver through direct activation of nuclear receptor CAR and PXR
沙利度胺通过直接激活核受体 CAR 和 PXR 增加肝脏细胞色素 P450 活性和药物代谢
  • 批准号:
    23590200
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Computational Methods for Modeling Cytochrome P450 Mediated Drug Metabolism
细胞色素 P450 介导的药物代谢建模的新计算方法
  • 批准号:
    8304931
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Novel Computational Methods for Modeling Cytochrome P450 Mediated Drug Metabolism
细胞色素 P450 介导的药物代谢建模的新计算方法
  • 批准号:
    8706177
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Novel Computational Methods for Modeling Cytochrome P450 Mediated Drug Metabolism
细胞色素 P450 介导的药物代谢建模的新计算方法
  • 批准号:
    7991977
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Novel Computational Methods for Modeling Cytochrome P450 Mediated Drug Metabolism
细胞色素 P450 介导的药物代谢建模的新计算方法
  • 批准号:
    8134421
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Novel Computational Methods for Modeling Cytochrome P450 Mediated Drug Metabolism
细胞色素 P450 介导的药物代谢建模的新计算方法
  • 批准号:
    8515459
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Drug metabolism in the Brain: Expression and Regulation of Cytochrome P450
大脑中的药物代谢:细胞色素 P450 的表达和调节
  • 批准号:
    179026
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Phase 2 SBIR: Zebrafish Cytochrome P450 Assays for Assessing Drug Metabolism and
第 2 阶段 SBIR:斑马鱼细胞色素 P450 检测,用于评估药物代谢和
  • 批准号:
    7848598
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了